Cost-effectiveness of PCSK9 inhibition in addition to standard lipid-lowering therapy in patients at high risk for vascular disease
| Autor: | Stam-Slob, Manon C., van der Graaf, Yolanda, de Boer, Anthonius, Greving, Jacoba P., Visseren, Frank L.J. |
|---|---|
| Zdroj: | In International Journal of Cardiology 15 February 2018 253:148-154 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect